International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 2 (March-April 2026) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 2
March-April 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Pharma 4.0 Ai-Integrated 3d Printing as The Future of Personalised Drug Development

Author(s) Ms. Leena Ravindra Thakare, Ms. Kirti Chandrakant Shelar, Ms. Priyanka Manoharan Molakar, Ms. Priyanka Arun Sawant
Country India
Abstract Three-dimensional (3D) printing is a disruptive technology for pharmaceutical sciences and provides a platform on which highly complex, individualized drug delivery systems can be designed and manufactured. 3D printing allows control over dosage, geometry, and drug release properties, meeting patient-specific needs such as those of the paediatric, geriatric, and polypharmacy populations. Following the first approval of a 3D-printed product by the FDA (Spritam®), 3D printing began to be utilized to produce modified-release tablets, multi-drug dosage forms, and chewable dosage forms. Efforts to capitalize on the incorporation of Artificial Intelligence (AI) in the field have permitted the development and use of predictive modelling and real-time quality monitoring. Even with these benefits of 3D printing—rapid prototyping and a wide range of formulation capabilities—3D printing faces challenges of industrial adaptability, limits to currently available excipients, and the complexity of regulatory pathways. Future work will focus on the combination of 3D printing with AI, nanotechnology, and bioprinting to completely revolutionize the processes and practices of pharmaceutical manufacturing and to support future innovations in precision medicine.
Keywords 3d Printing, Pharmaceutical Manufacturing, Artificial Intelligence, Personalized Medicine, Drug Delivery
Field Medical / Pharmacy
Published In Volume 8, Issue 1, January-February 2026
Published On 2026-02-18
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 2Cover Page Vol 8 Isu 1Cover Page Vol 7 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com
Powered by Sky Research Publication and Journals